Recurrent Urinary Tract Infections
13
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (13)
WMT for Recurrent Urinary Tract Infections
Emotional Urinary Tract Infection
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
Comparison of Three Different Antibiotic Treatments Against Recurrent Urinary Tract Infections in Catheterized Patients
Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study
Vaginal and Urinary Microbiome Trial
D Mannose for Prevention and Treatment of RUTIs
D-mannose for the Prevention of UTIs in Multiple Sclerosis
Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections
Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection